ArticleBMC ophthalmology2026
Recurrent rhegmatogenous retinal detachment: incidence, established and emerging risk factors, and clinical outcomes.
Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRecurrent rhegmatogenous retinal detachment (RRD) remains a significant cause of visual morbidity despite advances in surgical techniques, and its determinants and clinical course are not yet fully defined. This study aimed to evaluate the incidence, risk factors, and outcomes of recurrent RRD in a large cohort at an Italian tertiary referral center.
methodsThis retrospective study included patients with primary RRD who underwent pars plana vitrectomy, scleral buckling, or both. Associations between clinical and intraoperative variables and recurrent RRD were analysed using multivariable logistic regression.
resultsA total of 209 eyes from 209 patients were included. The overall recurrence rate was 21.1%, with 52.3% of recurrences occurring within the first six postoperative weeks. Multivariate logistic regression identified proliferative vitreoretinopathy (PVR grade B or higher) (OR = 4.68, p = 0.006), high myopia (OR = 4.25, p = 0.002), preoperative glaucoma (OR = 4.08, p = 0.014), and systemic hypertension (OR = 2.72, p = 0.031) as independent predictors of recurrence. Final best-corrected visual acuity was significantly worse in eyes with recurrence (p < 0.001). Eyes with recurrent retinal detachment showed a significantly higher prevalence of cystoid macular edema.
conclusionsThis study confirms PVR and high myopia as risk factors for recurrent RRD and suggests preoperative glaucoma and systemic hypertension as additional predictors of recurrence. These findings highlight the importance of risk stratification in guiding individualized surgical planning, intensified early postoperative surveillance, and long-term follow-up to reduce recurrence and preserve visual outcomes.
Indexed as
Identifiers
42420903What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.